Table 1
Biomarkers to identify individuals with familial hypercholesterolemia who are at higher risk of major adverse cardiovascular outcomes. CAC: coronary artery calcification; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; ASCVD: atherosclerotic coronary vascular disease; Lp: lipoprotein; IAS: International Atherosclerosis Society; MESA: Multiethnic Study of Atherosclerosis.
| LDL-C AND TREATMENT ONSET10 | RISK BIOMARKERS32,41 | RISK EQUATIONS30,35 | IAS SEVERE FH DEFINITION10 | CAC SCORES31,39,43 |
|---|---|---|---|---|
|
| SAFEHEART risk equation30
MONTREAL FH Score35
|
|
|
[i] * Risk features: age > 40 years without treatment, smoking, male sex, lipoprotein(a) > 125 nmol/L (50 mg/dL), HDL-C < 40 mg/dL), hypertension, diabetes mellitus, family history of early cardiovascular disease in first-degree relatives (age < 55 years in men and < 60 years in women), chronic kidney disease (ie, estimated glomerular filtration rate < 60 mL/min per 1·73 m2, and BMI > 30 kg/m2